Literature DB >> 29031760

Impact of diagnosing and treating obstructive sleep apnea on healthcare utilization.

Robert J Walter1, Scott I Hagedorn2, Christopher J Lettieri3.   

Abstract

PURPOSE: Obstructive sleep apnea (OSA) contributes to an increased risk for multiple co-morbidities and decreased quality of life. As a result, OSA patients may have higher usage of healthcare resources which can be mitigated with effective treatment. This study evaluates changes in healthcare utilization (HCU) following the initiation of therapy for OSA.
METHODS: We conducted a retrospective study of newly diagnosed OSA patients. To assess total HCU, we incorporated the sum total of outpatient clinic encounters, laboratory tests, and medication prescriptions into a composite HCU score. Healthcare utilization for twelve months prior to positive airway pressure (PAP) was compared with twelve months after initiation of therapy. Reductions in HCU were correlated with PAP adherence.
RESULTS: 650 consecutive patients were included. Mean age, gender, BMI, AHI, and ESS were 47.2 ± 8.8 years, 77.2% (men), 30.7 ± 4.9 kg/m2, 37.1 ± 30.3, and 13.1 ± 5.1, respectively. Prior to PAP, mean outpatient visits, laboratory studies, medication prescriptions, and HCU composite score were 11.6 ± 10.4, 13.7 ± 11.0, 4.7 ± 3.2, and 29.7 ± 18.6, respectively. Following initiation of treatment, a 32.8% reduction in non-sleep outpatient visits was identified (p = 0.01) and a 16.4% decrease in laboratory studies (p = 0.02) was observed. There was a 19.9% reduction (p = 0.002) in HCU composite score. Those who were adherent with PAP had a 25.7% reduction in HCU composite score versus a 4.9% increase in those who discontinued PAP therapy (p < 0.001).
CONCLUSIONS: Diagnosing OSA and initiating PAP therapy resulted in a significant decrease in healthcare resource utilization. This reduction was greatest among those with higher baseline healthcare usage and those most adherent with therapy. Published by Elsevier B.V.

Entities:  

Keywords:  Cost; Health care utilization; Obstructive sleep apnea; PAP adherence

Mesh:

Year:  2017        PMID: 29031760     DOI: 10.1016/j.sleep.2017.07.020

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  7 in total

1.  Symptoms During CPAP Therapy Are the Major Reason for Contacting the Sleep Unit Between Two Routine Contacts.

Authors:  Heidi Avellan-Hietanen; Pirkko Brander; Adel Bachour
Journal:  J Clin Sleep Med       Date:  2019-01-15       Impact factor: 4.062

2.  Association of Positive Airway Pressure Use With Acute Care Utilization and Costs.

Authors:  Douglas B Kirsch; Hongmei Yang; Andréa L Maslow; Michael Stolzenbach; Andrea McCall
Journal:  J Clin Sleep Med       Date:  2019-09-15       Impact factor: 4.062

3.  The invisible costs of obstructive sleep apnea (OSA): Systematic review and cost-of-illness analysis.

Authors:  Ludovica Borsoi; Patrizio Armeni; Gleb Donin; Francesco Costa; Luigi Ferini-Strambi
Journal:  PLoS One       Date:  2022-05-20       Impact factor: 3.752

4.  Comorbidities associated with obstructive sleep apnea: a retrospective Egyptian study on 244 patients.

Authors:  Rania Ahmad Sweed; Salma Hassan; Nashwa Hassan Abd ElWahab; Soha Rashed Aref; Mahmoud Ibrahim Mahmoud
Journal:  Sleep Breath       Date:  2019-01-26       Impact factor: 2.816

5.  Failure of PAP Therapy to Alter the Trajectory of Health Care Utilization Among Patients With OSA: A Wake-up Call for the Field of Sleep Medicine or Just a Bad Dream?

Authors:  Karin G Johnson; Peter K Lindenauer
Journal:  Med Care       Date:  2018-11       Impact factor: 2.983

6.  Comprehensive management of obstructive sleep apnea by telemedicine: Clinical improvement and cost-effectiveness of a Virtual Sleep Unit. A randomized controlled trial.

Authors:  Vera M Lugo; Onintza Garmendia; Monique Suarez-Girón; Marta Torres; Francisco J Vázquez-Polo; Miguel A Negrín; Anabel Moraleda; Mariana Roman; Marta Puig; Concepcion Ruiz; Carlos Egea; Juan F Masa; Ramon Farré; Josep M Montserrat
Journal:  PLoS One       Date:  2019-10-24       Impact factor: 3.240

7.  Outpatient Respiratory Management of Infants, Children, and Adolescents with Post-Prematurity Respiratory Disease: An Official American Thoracic Society Clinical Practice Guideline.

Authors:  A Ioana Cristea; Clement L Ren; Reshma Amin; Laurie C Eldredge; Jonathan C Levin; Parevi P Majmudar; Anne E May; Rebecca S Rose; Michael C Tracy; Karen F Watters; Julian Allen; Eric D Austin; Mary E Cataletto; Joseph M Collaco; Robert J Fleck; Andrew Gelfand; Don Hayes; Marcus H Jones; Sheila S Kun; Erica W Mandell; Sharon A McGrath-Morrow; Howard B Panitch; Rizwana Popatia; Lawrence M Rhein; Alejandro Teper; Jason C Woods; Narayan Iyer; Christopher D Baker
Journal:  Am J Respir Crit Care Med       Date:  2021-12-15       Impact factor: 21.405

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.